charles river Endosafe Trillium rCR cartridges

« Previous article

8th June 2022  Content supplied by: Gradientech AB

Gradientech’s Diagnostic System QuickMIC® Achieves CE-IVD Approval

“CE-IVD registration is an important milestone for Gradientech. Together with the successful results of the clinical study, the QuickMIC system is now ready for the European market. Today I feel very proud and happy as we after years of hard work can offer next generation diagnostics of antibiotic susceptibility testing in a globally very important and prioritized area”, says Sara Thorslund, CEO of Gradientech.

The QuickMIC system’s ultra-rapid and precise results enable patients with sepsis to quickly receive specific personalized guidance of the right antibiotics in the right dose. The modular design makes it flexible and allows hospitals to start on a small scale and then scale up as needed.

“There is a presently unmet medical need for rapid availability of phenotypic susceptibility data for Gram-negative organisms. QuickMIC meets this need and can play a crucial role in the hospitals’ important work to essentially improve care in sepsis patients,” says Holger Rohde MD Prof. Molecular Microbiology, Hamburg-Eppendorf University Hospital.

Visit Gradientech or click on the Request Information button below

Share on:


Date Published: 8th June 2022

Source article link: View

View full company details

« Previous article